CENTERS FOR MEDICARE & MEDICAID SERVICES

Bills and resolutions

Dept. of HHS: develop a joint action plan to reduce single use drug waste and better manage costs relative to drug vial sizes and drug delivery systems (see H.R. 5867), H4209 [17MY] (see H.R. 6142), H5284 [19JN]

——— make available on Centers for Medicare & Medicaid Services website opioid prescribing guidance for certain Medicare beneficiaries and update such guidance periodically (see H.R. 5777), H3934 [11MY]

——— reduce racial disparities in maternal mortality and morbidity through supporting implicit bias training, pregnancy medical home programs, and incorporating bias recognition in medical school skills testing (see S. 3363), S5831 [22AU] (see H.R. 6698), H7824 [4SE]

Diseases and disorders: accelerate progress toward prevention strategies, treatments, and a cure for Alzheimer’s disease and related dementias and provide caregivers dementia care training (see S. 2387), S703 [7FE] (see H.R. 4957), H973 [7FE]

Drugs: provide for an action plan to prevent opioid addictions and enhance access to medication-assisted treatment (see S. 2769), S2484 [26AP] (see H.R. 5590), H3505 [24AP]

——— require drug manufacturers to disclose prices of prescription drugs in any direct-to-consumer advertising and marketing to practitioners of a drug (see H. Con. Res. 146), H10511 [20DE]

Health care facilities: develop and identify indicators of potentially fraudulent and disreputable recovery housing operators (see S. 2828), S2623 [10MY] (see H.R. 6092), H5152 [13JN]

Health care professionals: authorize grants for graduate medical education partnerships in States with a low ratio of medical residents relative to population (see H.R. 7233), H9819 [10DE]

Insurance: disapprove rule on definition of short-term limited duration insurance for purposes of its exclusion from the definition of individual health insurance coverage (see S.J. Res. 63), S5991 [28AU] (see H.J. Res. 140), H8725 [13SE]

Medicaid: compel manufacturers to correct inaccurate classification data reported to rebate program (see H.R. 5712), H3833 [8MY]

——— prevent misclassification of drugs for purposes of the drug rebate program (see S. 3702), S7275 [4DE] (see H.R. 7223), H9767 [6DE]

Medicare: apply secondary payer rules to certain workers’ compensation settlement agreements and qualified set-aside provisions (see S. 3079), S3982 [18JN] (see H.R. 6619), H7723 [26JY]

——— permit review of certain payment determinations for disproportionate share hospitals (see S. 2690), S2218 [17AP] (see H.R. 5985), H4736 [29MY]

Medicare/Medicaid: improve access to care for beneficiaries through models tested under Center for Medicare & Medicaid Innovation (see H.R. 6601), H7723 [26JY]

Mental health: provide for testing of clinical psychologist services models (see H.R. 5790), H3975 [15MY]

National Pressure Ulcer/Injury Prevention Day: designate (see H. Res. 1133), H9448 [26OC]

Letters

Rule on definition of short-term limited duration insurance for purposes of its exclusion from the definition of individual health insurance coverage: National Association of Insurance Commissioners, S6741 [10OC]

——— several healthcare organizations, S6740 [10OC]

Remarks in House

Drugs: provide for an action plan to prevent opioid addictions and enhance access to medication-assisted treatment (H.R. 5590), H5247–H5249 [19JN]

Medicaid: prevent misclassification of drugs for purposes of the drug rebate program, H10050, H10051 [11DE]

Medicare: eliminate cuts to disproportionate share hospital (DSH) payments, H895 [6FE]

Mental health: provide for testing of clinical psychologist services models, H5252, H5253 [19JN]

National Pressure Ulcer/Injury Prevention Day: designate (H. Res. 1133), E1532 [16NO]

Patient and State Stability Fund: establish to give States flexibility in how they provide assistance for health insurance costs (H.R. 4666), H789 [6FE]

Remarks in Senate

Diseases and disorders: accelerate progress toward prevention strategies, treatments, and a cure for Alzheimer’s disease and related dementias and provide caregivers dementia care training (S. 2387), S1135 [15FE]

Insurance: disapprove rule on definition of short-term limited duration insurance for purposes of its exclusion from the definition of individual health insurance coverage (S.J. Res. 63), S6708–S6710, S6713, S6717–S6719 [9OC], S6736–S6744, S6749, S6755–S6758, S6762, S6767 [10OC], S6779, S6794 [11OC]

Medicaid: prevent misclassification of drugs for purposes of the drug rebate program (S. 3702), S7339 [6DE]

Reports filed

Opioid Addiction Action Plan Act: Committee on Energy and Commerce (House) (H.R. 5590) (H. Rept. 115–746), H5092 [12JN]

Statements

Short Term Medical Plans: Golden Rule Insurance Co., S6741 [10OC]

Texts of

H.R. 5590, Opioid Addiction Action Plan Act, H5247 [19JN]